Grapefruit USA, Inc. (GPFT)
OTCMKTS · Delayed Price · Currency is USD
0.0019
+0.0002 (13.10%)
Aug 1, 2025, 3:52 PM EDT
Grapefruit USA Market Cap
Grapefruit USA has a market cap or net worth of $2.10 million as of August 1, 2025. Its market cap has increased by 111.11% in one year.
Market Cap
2.10M
Enterprise Value
n/a
Revenue
34.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 3, 2019, Grapefruit USA's market cap has decreased from 61.15M to 2.10M, a decrease of -96.56%. That is a compound annual growth rate of -42.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.10M | 216.67% |
| Dec 31, 2024 | 664.03K | -53.85% |
| Dec 29, 2023 | 1.44M | -77.05% |
| Dec 30, 2022 | 6.27M | -40.79% |
| Dec 31, 2021 | 10.59M | -75.31% |
| Dec 31, 2020 | 42.88M | 19.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.98M |
| Northwest Biotherapeutics | 351.67M |